Dr. Joseph D'Orazio is board certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. He practices Medical Toxicology and Addiction Medicine for the Cooper Center for Healing at Cooper University Hospital in Camden, NJ. Dr. D’Orazio cares for patients who are admitted to Cooper University Hospital through the addiction medicine and toxicology inpatient consultative service and through the Cooper Center for Healing outpatient offices. Dr. D’Orazio is a medical toxicologist for the Poison Control Center at Children’s Hospital of Philadelphia and is regarded as a regional expert in substance use and substance use disorder treatment in the Philadelphia area.

Jennie Duval was appointed Chief Medical Examiner for the State of New Hampshire on October 1, 2017 after serving as the Deputy Chief Medical Examiner for over 15 years. She earned her undergraduate degree from the University of New Hampshire and her medical degree from McGill University, Montreal, Quebec. She completed pathology residency training at the University of Massachusetts Medical Center and forensic pathology fellowship training at the Office of the Chief Medical Examiner in Boston. She teaches pathology and forensic pathology to medical students, physician assistant students and pathology residents at various institutions in New Hampshire. In addition, she has published several journal articles, presented numerous scientific papers at national professional society meetings and lectures frequently on various topics in forensic pathology including drug related deaths. During her career she has performed over 6,600 autopsies including over 1,700 drug related deaths.

James R. Gill MD is the Chief Medical Examiner of Connecticut, past Chair of the Forensic Pathology Committee of the College of American Pathologists (CAP), and a past President of the National Association of Medical Examiners (NAME).  He has faculty medical appointments at Yale, University of Connecticut, and Quinnipiac University.  He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and his forensic pathology fellowship at the New York City Office of Chief Medical Examiner.  Prior to Connecticut, he was the Deputy Chief Medical Examiner for Bronx County.  He has testified over 450 times in criminal and civil matters in State and Federal courts and has published over 100 scientific articles and book chapters, and two books on a variety of forensic pathology topics.  He has particular interests in public health including drug intoxication deaths, infectious disease, fatal complications of therapy, and proper death certification.

Dr. Andrew Holt received his Doctor of Pharmacy degree from the University of Tennessee Health Science Center and is licensed to practice in multiple states. Prior to joining Aegis, Dr. Holt worked for the Tennessee Board of Pharmacy as Executive Director and was Director of Tennessee’s Prescription Drug Monitoring Program. He holds additional certifications in medical affairs, pharmacogenomics, and drugs in sport. Dr. Holt is an assistant professor for the Department of Clinical Pharmacy and Translational Science at the University of Tennessee College of Pharmacy, serves as a preceptor for six colleges of pharmacy and is a co-Director of the post-doctoral Fellowship Program, a collaboration with Belmont College of Pharmacy. One of his primary interests is the surveillance and detection of novel psychoactive substances and their role in overdoses.

Dr. Sherri Kacinko is a senior toxicologist at NMS Labs in Horsham, PA. She earned her Ph.D. in toxicology from the University of Maryland – Baltimore. She is also adjunct faculty in the chemistry and forensic science departments at Arcadia University and serves as an Instructor at the Center for Forensic Science Research & Education.  In her teaching roles, Dr. Kacinko lectures in pharmacology, postmortem toxicology, and human performance toxicology courses. 

Dr. Kacinko is a fellow of the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists, the International Association of Forensic Toxicologists, and the American Academy of Forensic Sciences. She was presented with the American Academy of Forensic Sciences Toxicology Section Irving Sunshine Award in recognition of early career research and served as the program chair, secretary and chair of the AAFS toxicology section.

Current research interests include the identification and quantification of novel psychoactive substances and esoteric drugs including synthetic cannabinoids, stimulants, hallucinogens, opioids and benzodiazepines in biological fluids and their toxicological impact. Dr. Kacinko also uses data analytics to monitoring drug use trends on a local and national level.

Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.

Dr. Barry Logan is Sr. vice president of Forensic Sciences, and Chief Scientist for NMS Labs. He is also Executive Director at the non-profit Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in Willow Grove, Pennsylvania. 

Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over 190 publications in forensic toxicology and chemistry, including work on the effects of illicit and prescription drugs on drivers, and drug caused and related death. His current research priorities are focused on new drug surveillance and trends, the polydrug crisis, and the analytical and interpretive toxicology and chemistry of novel psychoactive substances, founding www.NPSDiscovery.org in 2018.

Dr. Logan’s has academic appointments at Indiana University, Arcadia University and Thomas Jefferson University in Philadelphia. He serves on the Advisory Board for NIDA’s National Drug Early Warning System (NDEWS). In recognition of his work and contributions, Dr. Logan received TIAFT’s Alan Curry Award in 2022, and is a past President of the American Academy of Forensic Sciences (AAFS).

 Karen has over fifteen years of public sector experience, where she has informed public policy and contributed to health systems change. She has spent the past five years leading the design and implementation of Toronto’s Drug Checking Service, and is now responsible for the program’s continuation and expansion across Ontario. Karen has received international recognition as a leader in drug checking service provision and unregulated drug market surveillance and education.

Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

M.J. Menendez, J.D. is Senior Fellow and General Counsel for the Center for Forensic Science Research and Education in Willow Grove, Pennsylvania.  M.J. served on detail as the Department of Justice’s Organized Crime Drug Enforcement Task Forces Heroin, Opioid and Fentanyl Special Projects Coordinator from 2015 to 2019.  M.J. served 13 years as an Assistant U.S. Attorney in Colorado, 10 years as a state prosecutor in Jefferson County, Colorado, and 3 years as a state court judge in Jefferson County, Colorado.  M.J. is passionate about achieving well-resourced excellence in medicolegal death investigations, and she proudly works with the National Association of Medical Examiners as Chair of Strategic Planning and Chair of the Forensic Pathology Shortage / Workforce Remediation Subcommittee.

Donna Papsun is a forensic toxicologist and business scientist with NMS Labs in Horsham, PA. She has dual Bachelor of Science degrees in Chemistry and Forensic & Investigative Science and a Master of Science degree in Pharmacology. She is also certified as a Diplomate in Forensic Toxicology through the American Board of Forensic Toxicology and is a member of both the Society of Forensic Toxicologists (SOFT) and the American Academy of Forensic Sciences (AAFS). 

Ms. Papsun has been with NMS Labs since 2008, first as a bench analyst before promotion to toxicologist in 2012. Ms. Papsun’s main area of interest is novel psychoactive substances or NPS. As one of the two leaders of NMS’s NPS strategy team, she continuously works to help maintain NMS’s leadership in identifying the newest trends in the changing landscape of the designer drug market and developing tests for their detection in forensic toxicology casework. Ms. Papsun also serves in a secondary role as a business scientist, working to align the technical and scientific expertise of NMS Labs with commercial efforts.

Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.